Eileen Holderman
Eileen Holderman is an advocate for ME, GWI and other neuroimmune diseases and serves as consultant to ME Advocacy. Holderman was a voting member of the Chronic Fatigue Syndrome Advisory Committee (CFSAC) which advises the U.S. Department of Health and Human Services for the term 10 May 2010 to 10 May 2014.[1] She is active in the New Jersey ME/CFS Association having served as a Trustee and as its Publicity/Advocacy Chair.[2]
Contents
Talk and interviews[edit | edit source]
CFSAC testimony[edit | edit source]
- Jun 17, 2014, CFSAC Written/Public Comment
- Aug 2015, CFSAC Public Comment: Eileen Holderman
- May 18, 2016, Public comments to CFSAC meeting regarding NIH study.
- Jan 13, 2016, Public comments to CFSAC meeting regarding CDC website.
Letter to CDC[edit | edit source]
Online presence[edit | edit source]
- Website/Blog
- YouTube
Learn more[edit | edit source]
- Jul 20, 2009, Eileen Holderman – ME/CFS Advocate by ProHealth
See also[edit | edit source]
- List of Chronic Fatigue Syndrome Advisory Committee Members
- Chronic Fatigue Syndrome Advisory Committee
References[edit | edit source]
Chronic Fatigue Syndrome Advisory Committee (CFSAC) - (sometimes pronounced SIF-SACK) A US government advisory council that met twice per year, covering current topics related to Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. Meetings usually lasted for two days and the results were presented to the Secretary of Health and Human Services (HHS). After 15 years, on September 5, 2018, CFSAC's charter was not renewed by the Department of HHS, effectively dissolving the committee without notice or warning.
Centers for Disease Control and Prevention (CDC) - The Centers for Disease Control and Prevention is a U.S. government agency dedicated to epidemiology and public health. It operates under the auspices of the Department of Health and Human Services.
The information provided at this site is not intended to diagnose or treat any illness.
From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history.